A 12-year review of S.aureus bloodstream infections in haemodialysis patients
本帖最后由 拙凌 于 2012-2-27 10:30 编辑A 12-year review of Staphylococcus aureus bloodstream infections in haemodialysis patients.
Staphylococcus aureus bloodstream infections (BSI) are a significant cause of morbidity and mortality in haemodialysis patients. This study describes a 12-year retrospective review of S. aureus BSI in a large haemodialysis centre in a tertiary referral hospital. The overall rate of S. aureus BSI was 17.9 per 100 patient-years (range 9.7-36.8). The rate of meticillin-resistant S. aureus (MRSA) BSI was 5.6 per 100 patient-years (range 0.9-13.8). Infective complications occurred in 11% of episodes, the most common being infective endocarditis (7.6%). Ten percent of patients died within 30 days of S. aureus being isolated from blood. Most cases of S. aureus BSI (83%) were related to vascular catheters. The provision of lower-risk vascular access, such as arteriovenous fistulae, and reduced use of intravascular catheters should be priorities in all haemodialysis units. Where alternative vascular access cannot be established, interventions to reduce the risk of catheter-related infections should be implemented to reduce morbidity and mortality in this vulnerable patient group. (C) 2011 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
复制学习，英文资料还是由多数人员看的不太明白，译成中文，有对照就好了。试着看看，谢谢！
页:
[1]